Chris Hilger is the CEO of
SolisRx , a boutique revenue cycle analytics consultancy specializing in multi-site infusion and specialty pharmacy organizations. Since launching SolisRx in 2023, the team has launched 100+ analytics and workflow automation solutions designed to accelerate performance across four core growth areas: referrals, intake operations, revenue cycle, and market expansion.
Chris holds a Master’s in Health Data Science from Harvard and was selected to present at NICA 2025 and NHIA 2026 on topics including infusion analytics, intake workflow visibility, and automation. His insights were featured in Bourne Partners’ 2025 Infusion Market Update, and he continues to work closely with operators and investors to drive sustainable growth through better data.
